ReviewJournal of the Endocrine Society2026

Personalization of incretin therapy: can GLP-1 and GIP receptor polymorphisms influence therapy response?

Sandro La Vignera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.